Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 5.76 |
|---|---|
| High | 6.34 |
| Low | 5.76 |
| Bid | 6.05 |
| Offer | 6.30 |
| Previous close | 6.00 |
| Average volume | 157.21k |
|---|---|
| Shares outstanding | 10.65m |
| Free float | 8.52m |
| P/E (TTM) | -- |
| Market cap | 63.92m USD |
| EPS (TTM) | -1.02 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway
- NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
- NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
- NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
- NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
- NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
- NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
- NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
- NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
- NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
More ▼
